News and Press Releases


Argonne National Laboratory Demonstration of SHINE Process Produces Commercial-Grade Medical Isotopes

June 15, 2015 – Argonne National Laboratory (Argonne) and SHINE Medical Technologies, Inc. announced today that Argonne successfully demonstrated the production, separation and purification of molybdenum-99 (Mo-99) from SHINE’s innovative liquid target. The resulting Mo-99 product purity was equivalent to the Mo-99 used in the supply chain today. The demonstration—known as Mini-SHINE— uses the same process flows that will be used in the SHINE manufacturing facility and further validates SHINE’s technical approach.

Shine Medical Technologies Logo

SHINE To Hold Information Meeting on June 17, 2015

June 12, 2015 – SHINE Medical Technologies invites the Janesville community to an update on the development of its medical isotope facility. SHINE has made significant technical, strategic and regulatory progress since our last community meeting in December 2014. The meeting will take place on Wednesday, June 17th at the Holiday Inn Express, 3100 Wellington Place in Janesville. The presentation is scheduled from 4:30-5:30 p.m. There will be an opportunity at the end of the presentation for questions.


Nuclear Regulatory Commission Issues Draft Environmental Impact Statement for SHINE Facility

May 21, 2015 – SHINE Medical Technologies, a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, announced today that the Company’s primary regulator, the Nuclear Regulatory Commission (NRC), has released for public review and comment the draft Environmental Impact Statement (EIS) for the SHINE medical isotope production facility in Janesville, WI.


BrightStar Wisconsin invests in SHINE

BrightStar Wisconsin Foundation Inc. today announced that it has invested a total of $1 million in five additional companies, Dairyvative Technologies  LLC, Shine Medical Technologies Inc., Fetch Rewards Inc., Medical Companion LLC (doing business as mPirik), and Keystone Insights Inc.


SHINE Medical Technologies and Phoenix Nuclear Labs Sign Multi-year Development and Supply Agreement

January 7, 2015 – SHINE Medical Technologies and Phoenix Nuclear Labs (PNL) announced today that they have entered into an exclusive, long-term development and supply agreement. This agreement builds on an existing partnership and lays the foundation for a commercial relationship going forward.

SHINE Stays Ahead of The Competition: Founder

There’s no shortage of companies that want to fill an impending gap in North American medical isotope production.

A Google search offers plenty of evidence, said Greg Piefer, founder and chairman of SHINE Medical Technologies, the company that starting in 2018 plans to make molybdenum-99 and other medical isotopes in Janesville.


SHINE Offers New Technology to Alleviate Mo-99 Shortage

Since the severe global molybdenum-99 (Mo-99) shortage of 2009 and 2010, nuclear medicine practitioners have been glancing back over their collective shoulders to see when the next crisis might occur. Fortunately, plans are in the works to eliminate the angst of another medical isotope shortage, with one such effort coming from SHINE Medical Technologies.


Lantheus Medical Imaging and SHINE Medical Announce Mo-99 Supply Agreement

November 5, 2014 – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents, and SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, today announced that the companies have entered into a strategic agreement for the future supply of molybdenum-99 (Mo-99).